معرفی
Mette Holland-Fischer is a Clinical Associate Professor at Aalborg University's Faculty of Medicine, Department of Rheumatology, and serves as Chief Physician (Cheflæge) at Aalborg University Hospital's Department of Clinical Medicine. Her dual role bridges clinical practice and academic research in rheumatology, with a focus on autoimmune diseases and their complications.
Dr. Holland-Fischer's research primarily focuses on Psoriatic Arthritis, Ankylosing Spondylitis, and Rheumatoid Arthritis, with particular emphasis on disease activity, treatment response with TNF inhibitors, and infectious complications. Her work frequently employs population-based cohort methodologies to assess mortality risks and treatment effects, especially regarding pneumonia outcomes in rheumatic disease patients.
Her recent publications demonstrate a dual focus on clinical research regarding rheumatic disease complications and contributions to rheumatology education standards. She has been actively involved with EULAR (European Alliance of Associations for Rheumatology) initiatives to establish training standards for European rheumatologists, reflecting her commitment to advancing the field through both research and education.
Dr. Holland-Fischer has published 22 research outputs spanning from 2012 to 2023, with recent work appearing in high-impact rheumatology journals including Annals of the Rheumatic Diseases and RMD Open. Her research has garnered significant attention, with multiple publications being referenced in clinical guidelines and picked up by numerous news outlets.
As a clinical researcher and educator, Dr. Holland-Fischer contributes to advancing rheumatology practice through evidence-based research and participation in international standard-setting initiatives. Her work bridges the gap between clinical practice and academic research in autoimmune diseases, with implications for patient care and medical education standards across Europe.
